Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 30% ± 12% | |
endothelial cell | 9 studies | 24% ± 5% | |
endothelial cell of lymphatic vessel | 8 studies | 20% ± 4% | |
epithelial cell | 7 studies | 35% ± 13% | |
basal cell | 5 studies | 29% ± 7% | |
macrophage | 5 studies | 18% ± 1% | |
classical monocyte | 4 studies | 21% ± 4% | |
fibroblast | 4 studies | 20% ± 3% | |
glutamatergic neuron | 4 studies | 35% ± 12% | |
oligodendrocyte | 4 studies | 23% ± 1% | |
abnormal cell | 3 studies | 24% ± 7% | |
GABAergic neuron | 3 studies | 36% ± 2% | |
dendritic cell | 3 studies | 31% ± 5% | |
goblet cell | 3 studies | 18% ± 2% | |
transit amplifying cell | 3 studies | 25% ± 7% | |
neuron | 3 studies | 22% ± 6% | |
natural killer cell | 3 studies | 17% ± 1% | |
astrocyte | 3 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5686.02 | 1445 / 1445 | 100% | 129.68 | 183 / 183 |
breast | 100% | 6488.56 | 459 / 459 | 100% | 186.56 | 1117 / 1118 |
ovary | 100% | 4615.28 | 180 / 180 | 100% | 69.46 | 429 / 430 |
lung | 100% | 4172.91 | 577 / 578 | 100% | 126.16 | 1154 / 1155 |
stomach | 100% | 4401.19 | 359 / 359 | 99% | 110.90 | 284 / 286 |
intestine | 100% | 5801.65 | 966 / 966 | 99% | 114.43 | 523 / 527 |
prostate | 100% | 3689.61 | 245 / 245 | 99% | 108.29 | 498 / 502 |
uterus | 100% | 4807.36 | 170 / 170 | 99% | 102.96 | 454 / 459 |
bladder | 100% | 5083.14 | 21 / 21 | 99% | 104.28 | 498 / 504 |
liver | 100% | 4149.31 | 226 / 226 | 99% | 102.15 | 401 / 406 |
pancreas | 99% | 2848.26 | 325 / 328 | 99% | 84.02 | 177 / 178 |
brain | 99% | 3196.40 | 2607 / 2642 | 100% | 65.84 | 703 / 705 |
thymus | 100% | 4331.79 | 653 / 653 | 98% | 79.10 | 595 / 605 |
skin | 100% | 7724.68 | 1809 / 1809 | 98% | 161.24 | 464 / 472 |
kidney | 100% | 4121.39 | 89 / 89 | 98% | 88.74 | 879 / 901 |
adrenal gland | 100% | 8509.52 | 258 / 258 | 88% | 64.85 | 203 / 230 |
adipose | 100% | 7005.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5885.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 78.58 | 29 / 29 |
muscle | 100% | 6893.22 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3793.41 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.25 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 93.24 | 44 / 45 |
heart | 95% | 4758.89 | 815 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 65.48 | 74 / 80 |
peripheral blood | 67% | 2689.99 | 624 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0106074 | Biological process | aminoacyl-tRNA metabolism involved in translational fidelity |
GO_0006428 | Biological process | isoleucyl-tRNA aminoacylation |
GO_0006418 | Biological process | tRNA aminoacylation for protein translation |
GO_0032543 | Biological process | mitochondrial translation |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0000049 | Molecular function | tRNA binding |
GO_0004822 | Molecular function | isoleucine-tRNA ligase activity |
GO_0002161 | Molecular function | aminoacyl-tRNA editing activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | IARS2 |
Protein name | Alternative protein IARS2 Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS) |
Synonyms | |
Description | FUNCTION: Aminoacyl-tRNA synthetase that catalyzes the specific attachment of isoleucine to its cognate tRNA (tRNA(Ile)). . |
Accessions | L8EA13 Q9NSE4 ENST00000366922.3 L8E8E9 |